While the Trump administration is focused on cutting costs, addressing the gaps in care for millions of Americans with ...

has received a licence from Defence Research and Development Organisation (DRDO) to Manufacture and Market of ‘2-Deoxy-D-Glucose’ as approved medication for the treatment of COVID-19 patients”.

Researchers at McMaster University say they've created Canada ... research team needs more funding to continue its work. "Funding has stopped but evidence is continuing to emerge and long COVID ...